|
KMID : 1023520230460030249
|
|
Korean Journal of Veterinary Service
2023 Volume.46 No. 3 p.249 ~ p.253
|
|
|
Toceranib therapy for hepatic fibrosarcoma in a dog
|
|
Park Mi-Kyung
Song Kun-Ho
|
|
|
Abstract
|
|
|
|
A 12-year-old neutered male Maltese was brought to our hospital with loss of appetite, generalized alopecia, anemia, and a palpable abdominal mass. Ultrasonography revealed multiple abdominal masses in the liver and spleen. Subsequently, splenectomy and liver biopsy were performed, and the masses were histologically diagnosed as metastatic fibrosarcomas of unknown primary origin. The owner refused further investigations such as computed tomography and hepatectomy, therefore, we decided to initiate chemotherapy in the form of metronomic therapy with toceranib phosphate, which has several advantages, such as better tolerability, low cost, and convenience. The size and number of hepatic fibrosarcomas continued to increase despite continued administration of toceranib (10 mg/dog, PO, q48h). The dog died approximately 43 days after initiation of the toceranib treatment. To the best of our knowledge, this is the first report on toceranib therapy for metastatic hepatic fibrosarcoma in a dog.
|
|
|
KEYWORD
|
|
|
Dog, Liver, Fibrosarcoma, Toceranib
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|